OL
Oncology Letters
1792-1074
1792-1082
D.A. Spandidos
10.3892/ol.2023.13825
OL-25-6-13825
Retraction
[Retracted] Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM‑9 through regulating the SIRT1‑NF‑κB pathway
BoJian
WangXiaojuan
LiJie
WangWenqing
ZhangJinqian
06
2023
19
04
2023
25
6
239
Copyright: © Bo et al.
2023
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
Oncol Lett 14: 433–440, 2017; DOI: 10.3892/ol.2017.6114
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the histone-3 and β-actin western blot data shown in Fig..3 were strikingly similar, albeit the bands appeared to have been placed into the figure in different orientations; in addition, certain of the western blotting data shown in Fig. 4 were strikingly similar to data that had appeared in different form in different articles published by (largely) different authors.
Owing to the fact that some of the data in the above article had already been published prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience caused.